Related Experiment Video
Updated: Mar 17, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Duration of Antibiotic Therapy for Bacteremia in the Critically Ill: A Mythologic Chimera?
Alberto Corona1, Claudia Ruffini, Lorenzo Rota
1Intensive Care Unit, Azienda Ospedaliera Luigi Sacco, University of Milano, Milano, Italy.
No abstract available in PubMed .
More Related Videos
07:44Time-Lapse Epifluorescence Microscopy Imaging of Pseudomonas aeruginosa and Staphylococcus aureus Heterogeneous Phenotypes
Published on: February 14, 2025
07:46Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
Published on: June 5, 2012
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Urine Studies II: Urine Culture and Sensitivity Test
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: